← Oncology Approval Tracker

FDA DECISION ·

Jemperli

dostarlimab-gxly · GlaxoSmithKline

Traditional approvalTraditional conversionEndometrial cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with recurrent or advanced dMMR endometrial cancer after progression during or after platinum therapy, when curative surgery or radiation is unsuitable.

LAMPGEN ANALYSIS

Why it matters

The action converted the dMMR endometrial monotherapy use to traditional approval.

What research teams should watch

Verify the mismatch repair result, progression after platinum and eligibility for curative local treatment.

PRIMARY RECORDS

Sources